510(k) K163085
K163085 is an FDA 510(k) premarket notification submitted by Focus Diagnostics, Inc.:Dba Diasorin Molecular, LLC for the device "Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack". The FDA issued a decision of Substantially Equivalent on Feb 14, 2017. The device falls under product code OZN (C. Difficile Toxin Gene Amplification Assay), a Class II device regulated under 21 CFR 866.3130.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 14, 2017
- Date Received
- Nov 3, 2016
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- C. Difficile Toxin Gene Amplification Assay
- Device Class
- Class II
- Regulation Number
- 866.3130
- Review Panel
- MI
- Submission Type
- 510(k)
Amplification assay for the detection of c. Difficile toxin genes from stool specimens of symptomatic patients.
Need the full FDA record for Focus Diagnostics, Inc.:Dba Diasorin Molecular, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.